The National Screening Committee suggests annual retinal screening for all diabetic patients over the age of 12 years. Currently in the All Wales Adult CF service we arrange annual retinopathy screening for all patients on insulin therapy in their locality. Objective: To review the prevalence of diabetic retinopathy and maculopathy in adult CF patients on insulin therapy and predictors of retinopathy/maculopathy. To also review uptake of annual retinopathy screening appointments. Method: Age, sex, FEV1%, BMI, HbA1c, number of years on insulin, presence of retinopathy/maculopathy and attendance rate at retinal screen were examined for the year 2012. Results: 67 (40 female) of the 228 (29%) patients attending our centre in 2012 were receiving insulin therapy. The mean age (SD) and FEV1% were 29.3 years (9.1) and 57.9 (24.7) respectively. The mean (SD) HBA1c and BMI were 60.8 (18.4) and 22.2 (2.9) respectively. 43 of the 67 (64%) had a retinal screen in the last year of whom 18 (42%) had evidence of retinopathy (6 mild, 9 moderate, 2 preproliferative, 1 proliferative) and 6 also had maculopathy. Patients with retinopathy had higher HBA1c (69.4 p = 0.04) and mean number of years on insulin (10.7 years p < 0.001) than those without retinopathy. 36% of the patients on insulin did not attend screening in the last year. Age, sex and FEV1% did not predict attendance at retinal screen. Conclusions: Almost half the patients who attended screening had evidence of retinopathy. Over a third of patients did not attend screening appointments in 2012 suggesting we are missing an important treatable microvascular complication which will become more important in an ageing CF population.
Large artery haemodynamics are abnormal in adults with CF [1] but have not been explored in children. Carotid-femoral Pulse Wave Velocity (cfPWV) is a gold standard and independent measure of future risk in older subjects whilst augmentation index (AIx), a composite marker of arterial stiffness and wave reflection, is more closely associated with cardiovascular risk factors in younger subjects. Objectives: To measure large artery haemodynamics in children with CF and assess relationship to renal function (GFR), lung function, high sensitivity CRP (hsCRP) and Interleukin-6 (IL-6). Methods: CfPWV and AIx were measured in stable children with CF using applanation tonometry. GFR was measured by Chromium EDTA method. Lung function was assessed by spirometry and circulating hsCRP and IL-6 levels were measured. Results: With 28 participants (mean age 11.3 yrs., range 8.2-14.9), the mean supine AIx and PWV, adjusted for confounders, were 7.96% (SD 2.17) and 4.78 m/s (0.32) respectively. AIx was significantly greater (P < 0.0001, 95% CI 3.57 to 7.55) compared to previously published data [2] in children without lung disease (mean age 11.2 yrs). This was not manifest in standard peripheral BP. There was no significant association of AIx or PWV with GFR, lung function, log 10 hsCRP or log 10 IL-6. Conclusion: Increased AIx is present in children with CF, which is not explained by renal function, spirometry or the inflammatory markers measured. Evidence of early changes in the haemodynamics in children with CF warrants further research to explore pathogenesis in order to halt further progression. Objectives: To compare actual and patient perceived uptake of influenza and pneumococcal vaccination in the adult patients receiving care at the All Wales Adult CF centre to WHO targets. Methods: All patients attending for Annual review were asked if they had received influenza and pneumococcal vaccinations and to recall month/year of vaccination. Patients' GP were contacted to check record of vaccination administration. Results: 228 patients (123 male), mean age (SD) 28.1 years (9.3) were included and 100% of GP vaccination records were obtained. 169 (74%) patients had received influenza vaccine within the last year which falls just short of WHO (and Welsh Government) target of 75% in at risk groups. Of the 59 patients who did not receive the influenza vaccine 36 (61%) either thought they had received it or were unsure. 132 (58%) had received pneumococcal vaccine with a mean (SD) duration since receiving the vaccine of 5.5 (4.6) years. Of the 96 patients who had never received the vaccine 77 (80%) either thought they had received it or were unsure. Age, sex and FEV 1 % predicted were not predictors of influenza or pneumococcal vaccination uptake (p > 0.05). Conclusion: Recent Cochrane reviews of influenza and pneumococcal vaccination in patients with CF illustrate the paucity of evidence in this area. Currently it remains advised to follow immunisation schedules/targets and with an influenza vaccine uptake of 74% we are close to WHO targets. Interestingly a significant proportion of patients who had not received the vaccines thought they had had it or were unsure and this would have gone unnoticed had the GP vaccination record not been sought.
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